ciclopirox has been researched along with Uterine Cervical Neoplasms in 3 studies
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cervical cancer is one of the most common gynecological malignancies with poor prognosis due to constant chemoresistance and repeated relapse." | 1.72 | ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy. ( Bu, Y; Cui, L; Du, K; Fan, H; He, Y; Lei, Y; Li, Y; Wan, X; Wang, Y; Xiang, J; You, J; Zhang, C; Zhou, J, 2022) |
| "We found that proliferation of cervical cancer cells can be blocked by DOHH inhibition with either of these pharmacologic agents, as well as by RNA interference-mediated silencing of eIF5A, DOHH, or another enzyme in the hypusine pathway." | 1.40 | Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation. ( Cracchiolo, B; Hanauske-Abel, HM; Heller, DS; Hoque, M; Jain, MR; Li, H; Mathews, MB; Mémin, E; Pe'ery, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H | 1 |
| He, Y | 1 |
| Xiang, J | 1 |
| Zhou, J | 1 |
| Wan, X | 1 |
| You, J | 1 |
| Du, K | 1 |
| Li, Y | 1 |
| Cui, L | 1 |
| Wang, Y | 1 |
| Zhang, C | 1 |
| Bu, Y | 1 |
| Lei, Y | 1 |
| Braun, JA | 1 |
| Herrmann, AL | 1 |
| Blase, JI | 1 |
| Frensemeier, K | 1 |
| Bulkescher, J | 1 |
| Scheffner, M | 1 |
| Galy, B | 1 |
| Hoppe-Seyler, K | 1 |
| Hoppe-Seyler, F | 1 |
| Mémin, E | 1 |
| Hoque, M | 1 |
| Jain, MR | 1 |
| Heller, DS | 1 |
| Li, H | 1 |
| Cracchiolo, B | 1 |
| Hanauske-Abel, HM | 1 |
| Pe'ery, T | 1 |
| Mathews, MB | 1 |
3 other studies available for ciclopirox and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy.
Topics: Apoptosis; Autophagy; Ciclopirox; Female; Glycogen; Humans; Reactive Oxygen Species; Uterine Cervica | 2022 |
Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Topics: Antifungal Agents; Apoptosis; Cellular Senescence; Ciclopirox; DNA-Binding Proteins; Female; HCT116 | 2020 |
Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
Topics: Antifungal Agents; Cell Proliferation; Ciclopirox; Deferiprone; Eukaryotic Translation Initiation Fa | 2014 |